AR

Across TCGA pan-cancer cohorts, AR mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated AR data layer compared with 29 for mass-spec protein and 10 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher AR mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated AR expression acts as an unfavorable survival marker.

UCEC, CCRCC, and LSCC are the cancer types where AR mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	III,IV	0.312	1.000	.003	24	view →
CCRCC	DFS	Tertile	II,III,IV	0.753	1.000	.019	2	view →
LSCC	DFS	Tertile	All	0.430	1.000	.018	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

AR–UCEC (OS)

Open the UCEC breakdown →